journal article·2025-12Open access

Design of a Trigger‐Responsive Photothermal Vesicle‐Based Cargo Delivery Platform

Anastassiya Schramm, Nina F. Conzelmann, Ann‐Kathrin Gelmroth, Julia Köberle, Stefan Schramm, Rumiana Dimova, Ilia Platzman, Joachim Spatz

Small· Volume 21· Issue 51

Abstract

Abstract Cargo delivery systems enable the targeted transport of therapeutic agents to specific sites, enhancing treatment efficacy while minimizing systemic side effects. However, many existing systems struggle with achieving precise control over the release timing. Here, a photothermal trigger‐responsive delivery platform based on Giant Unilamellar Vesicles (GUVs) functionalized with gold nanorods (GNRs) is described to overcome these challenges. Toward this end, cargo‐loaded GUVs are produced using the emulsion transfer method and effective GNR attachment to the vesicle membrane is achieved by functionalizing the GNRs with cholesterol. The near‐infrared light (NIR)‐mediated cargo release mechanism is described. Importantly, high release efficiency is achieved by optimizing the cholesterol concentration on the GNRs, which is essential for controlling the GNR attachment mechanism to the GUV membrane. Finally, GNR‐functionalized ampicillin‐loaded GUVs are tested in the presence of E. coli bacteria to demonstrate the platform's functionality. Following NIR‐triggered antibiotic release, bacterial growth is inhibited. This showcases the practical potential of the developed trigger‐responsive system. Notably, GNR‐mediated photothermal heating alone also reduces bacterial viability upon extended illumination, indicating a dual antibacterial mechanism. This versatile and biocompatible system offers a controlled delivery method with broad applicability for therapeutics, diagnostics, and other biomedical applications.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Pickering emulsions and particle stabilization · Nanoparticle-Based Drug Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Cellular Biophysics Max Planck Institute for Medical Research Jahnstraße 29 69120 Heidelberg Germany

Max Planck School Matter to Life Jahnstraße 29 69120 Heidelberg Germany

Organic Chemistry University of Applied Sciences Dresden Friedrich‐List‐Platz 1 01069 Dresden Germany

Max Planck Institute of Colloids and Interfaces Science Park Golm 14476 Potsdam Germany

Max Planck‐Bristol Center for Minimal Biology University of Bristol Bristol BS8 1TD UK

Institute for Molecular Systems Engineering and Advanced Materials Heidelberg University Im Neuenheimer Feld 225 69120 Heidelberg Germany

Funding

Deutsche Forschungsgemeinschaft · Max-Planck-Gesellschaft · Bundesministerium für Bildung und Forschung

References (100+)

Show source-provided references
1. 10.1186/s40824-021-00226-610.1186/s40824-021-00226-6 ↗
2. 10.1016/j.jscs.2012.12.00910.1016/j.jscs.2012.12.009 ↗
3. 10.2147/JMDH.S31396810.2147/JMDH.S313968 ↗
4. 10.1038/s41551-021-00698-w10.1038/s41551-021-00698-w ↗
5. 10.1016/j.jconrel.2014.03.05410.1016/j.jconrel.2014.03.054 ↗
6. 10.3390/molecules2619590510.3390/molecules26195905 ↗
7. 10.1186/s40824-019-0156-z10.1186/s40824-019-0156-z ↗
8. 10.1038/s41576-021-00439-410.1038/s41576-021-00439-4 ↗
9. 10.1016/j.ijpharm.2013.11.04110.1016/j.ijpharm.2013.11.041 ↗
10. 10.1186/1743-8977-7-310.1186/1743-8977-7-3 ↗
11. 10.1021/acs.chemrev.5b0014810.1021/acs.chemrev.5b00148 ↗
12. 10.3390/ma1418537110.3390/ma14185371 ↗
13. 10.3390/pharmaceutics1502069510.3390/pharmaceutics15020695 ↗
14. 10.1186/s11671-021-03553-810.1186/s11671-021-03553-8 ↗
15. 10.1016/j.addr.2012.10.00210.1016/j.addr.2012.10.002 ↗
16. 10.1186/s12951-023-01826-110.1186/s12951-023-01826-1 ↗
17. 10.1007/s13758-011-0009-310.1007/s13758-011-0009-3 ↗
18. 10.1021/bc060080h10.1021/bc060080h ↗
19. 10.1021/jacsau.4c0004110.1021/jacsau.4c00041 ↗
20. 10.1039/D3NR01071F10.1039/D3NR01071F ↗
21. 10.1016/j.addr.2012.01.00210.1016/j.addr.2012.01.002 ↗
22. 10.1016/j.jconrel.2009.03.00710.1016/j.jconrel.2009.03.007 ↗
23. 10.1021/jz200093610.1021/jz2000936 ↗
24. 10.3390/pharmaceutics1412277710.3390/pharmaceutics14122777 ↗
25. Zhao Y. Z. · Int. J. Nanomed. · 2013 · 8 · 1621
26. 10.1016/j.jconrel.2019.03.03110.1016/j.jconrel.2019.03.031 ↗
27. 10.1021/ar500217w10.1021/ar500217w ↗
28. 10.4155/tde-2016-006010.4155/tde-2016-0060 ↗
29. 10.1021/es00169a00110.1021/es00169a001 ↗
30. 10.3390/pharmaceutics1403066410.3390/pharmaceutics14030664 ↗
31. 10.3390/molecules2209144510.3390/molecules22091445 ↗
32. 10.1016/j.sciaf.2020.e0068510.1016/j.sciaf.2020.e00685 ↗
33. 10.1016/j.jare.2010.02.00210.1016/j.jare.2010.02.002 ↗
34. 10.1063/1.311664510.1063/1.3116645 ↗
35. 10.1021/acs.bioconjchem.7b0080110.1021/acs.bioconjchem.7b00801 ↗
36. 10.1021/acsbiomaterials.2c0114210.1021/acsbiomaterials.2c01142 ↗
37. 10.1021/mz400301g10.1021/mz400301g ↗
38. 10.1007/s12274-022-5184-710.1007/s12274-022-5184-7 ↗
39. 10.1016/j.biomaterials.2020.12020310.1016/j.biomaterials.2020.120203 ↗
40. 10.2217/nmt-2018-003310.2217/nmt-2018-0033 ↗
41. Dimova R. · 2020
42. 10.1073/pnas.071087510510.1073/pnas.0710875105 ↗
43. 10.1016/j.tibtech.2020.08.00210.1016/j.tibtech.2020.08.002 ↗
44. Aleksanyan M. · Adv. Phys.: X · 2023 · 8
45. 10.1146/annurev-biophys-052118-11534210.1146/annurev-biophys-052118-115342 ↗
46. 10.1088/0953-8984/18/28/S0410.1088/0953-8984/18/28/S04 ↗
47. 10.1016/j.colsurfa.2021.12677810.1016/j.colsurfa.2021.126778 ↗
48. 10.1016/j.jconrel.2015.08.00310.1016/j.jconrel.2015.08.003 ↗
49. 10.1016/S0076-6879(09)64014-310.1016/S0076-6879(09)64014-3 ↗
50. 10.1016/j.ajps.2018.07.00610.1016/j.ajps.2018.07.006 ↗
51. 10.1016/j.ijpharm.2017.11.00210.1016/j.ijpharm.2017.11.002 ↗
52. 10.1002/jps.2198810.1002/jps.21988 ↗
53. 10.1016/j.colsurfa.2009.04.01410.1016/j.colsurfa.2009.04.014 ↗
54. 10.1016/j.jconrel.2006.04.01410.1016/j.jconrel.2006.04.014 ↗
55. 10.1016/j.molliq.2024.12508110.1016/j.molliq.2024.125081 ↗
56. 10.1016/j.rechem.2025.10223410.1016/j.rechem.2025.102234 ↗
57. 10.1080/02726351.2025.251727910.1080/02726351.2025.2517279 ↗
58. 10.1007/s40843-016-5101-310.1007/s40843-016-5101-3 ↗
59. 10.3390/nano1106149810.3390/nano11061498 ↗
60. 10.1016/j.jconrel.2007.06.00910.1016/j.jconrel.2007.06.009 ↗
61. 10.1021/acsomega.9b0120010.1021/acsomega.9b01200 ↗
62. 10.1016/j.jmrt.2018.03.00710.1016/j.jmrt.2018.03.007 ↗
63. 10.1021/jp057170o10.1021/jp057170o ↗
64. 10.1016/j.tiv.2015.01.01710.1016/j.tiv.2015.01.017 ↗
65. 10.1021/nn102722z10.1021/nn102722z ↗
66. 10.1002/adma.20120169010.1002/adma.201201690 ↗
67. 10.1039/c3ra48061e10.1039/c3ra48061e ↗
68. 10.1016/j.jcis.2013.04.02010.1016/j.jcis.2013.04.020 ↗
69. 10.1039/c3ra41873a10.1039/c3ra41873a ↗
70. 10.1002/jps.2088510.1002/jps.20885 ↗
71. 10.1016/S0006-3495(01)75729-310.1016/S0006-3495(01)75729-3 ↗
72. 10.1021/acs.langmuir.0c0159010.1021/acs.langmuir.0c01590 ↗
73. 10.1016/j.snb.2014.01.05610.1016/j.snb.2014.01.056 ↗
74. 10.1002/pro.238510.1002/pro.2385 ↗
75. 10.1002/cbic.20190052910.1002/cbic.201900529 ↗
76. 10.1016/j.nano.2020.10230010.1016/j.nano.2020.102300 ↗
77. 10.1038/s42004-021-00530-110.1038/s42004-021-00530-1 ↗
78. 10.1039/D4LC00380B10.1039/D4LC00380B ↗
79. 10.1016/0169-409X(89)90024-010.1016/0169-409X(89)90024-0 ↗
80. 10.1002/adhm.20120008410.1002/adhm.201200084 ↗
81. 10.1128/CDLI.8.6.1131-1135.200110.1128/CDLI.8.6.1131-1135.2001 ↗
82. 10.1021/acs.langmuir.6b0071610.1021/acs.langmuir.6b00716 ↗
83. 10.1038/s41589-020-00688-010.1038/s41589-020-00688-0 ↗
84. 10.1016/j.colsurfa.2021.12805410.1016/j.colsurfa.2021.128054 ↗
85. 10.1021/acsomega.6b0007910.1021/acsomega.6b00079 ↗
86. 10.1002/wnan.145010.1002/wnan.1450 ↗
87. 10.1016/j.colsurfb.2014.11.01910.1016/j.colsurfb.2014.11.019 ↗
88. 10.1039/b920629a10.1039/b920629a ↗
89. 10.1016/j.bpj.2009.07.01210.1016/j.bpj.2009.07.012 ↗
90. 10.1073/pnas.202501111810.1073/pnas.2025011118 ↗
91. 10.1103/PhysRevE.74.05150310.1103/PhysRevE.74.051503 ↗
92. 10.1021/la301771b10.1021/la301771b ↗
93. 10.3390/pharmaceutics1404070110.3390/pharmaceutics14040701 ↗
94. 10.1039/D0SM01027H10.1039/D0SM01027H ↗
95. 10.1039/D1NR08274D10.1039/D1NR08274D ↗
96. 10.1016/j.bbadva.2022.10005510.1016/j.bbadva.2022.100055 ↗
97. 10.3390/ijms1402351410.3390/ijms14023514 ↗
98. 10.1016/S0005-2736(03)00171-810.1016/S0005-2736(03)00171-8 ↗
99. 10.1021/jp411519k10.1021/jp411519k ↗
100. 10.1039/D1NA00010A10.1039/D1NA00010A ↗